Medicare Program; Meeting of the Medicare Evidence Development & Coverage Advisory Committee-March 18, 2009, 3051-3053 [E9-943]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–8003, CMS–
10185 and CMS–10164]
mstockstill on PROD1PC66 with NOTICES
Agency Information Collection
Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Home and
Community Based Waiver Requests and
Supporting Regulations in 42 CFR
440.180 and 441.300–310; Use: Under a
Secretarial waiver, States may offer a
wide array of home and communitybased services to individuals who
would otherwise require
institutionalization. States requesting a
waiver must provide certain assurances,
documentation and cost and utilization
estimates which are reviewed, approved
and maintained for the purpose of
identifying/verifying States’ compliance
with such statutory and regulatory
requirements. CMS has recently revised
this data collection tool, as well as the
methodology by which the data is
collected. Form Number: CMS–8003
(OMB # 0938–0449); Frequency:
Annually; Affected Public: State, Local
or Tribal Governments; Number of
Respondents: 49; Total Annual
Responses: 71; Total Annual Hours:
9,059.
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Part D
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
Reporting Requirements and Supporting
Regulations under 42 CFR 423.505;
Form Number: CMS–10185 (OMB #
0938–0992); Use: Title I, Part 423,
§ 423.514 describes CMS’ regulatory
authority to establish requirements for
Part D sponsors. It is noted that each
Part D plan sponsor must have an
effective procedure to develop, compile,
evaluate, and report to CMS, its
enrollees, and the general public, at the
times and in the manner that CMS
requires, statistics in the following
areas: (1) The cost of its operations; (2)
The availability of utilization of its
services; (3) The availability,
accessibility; and acceptability of its
services; (4) Information demonstrating
that the Part D plan sponsor has a
fiscally sound operation; and (5) other
matters that CMS may require.
Subsection 423.505 of the Medicare
Prescription Drug Modernization and
Modernization Act establishes as a
contract provision that Part D Sponsors
must comply with the reporting
requirements for submitting drug claims
and related information to CMS. Data
collected via Medicare Part D Reporting
Requirements will be an integral
resource for oversight, monitoring,
compliance and auditing activities
necessary to ensure quality provision of
the Medicare Prescription Drug Benefit
to beneficiaries. Refer to the ‘‘Crosswalk
of Changes between the CY2009 and
CY2010 Part D Reporting Requirements’’
document to view a list of current
changes. Frequency: Reporting—yearly,
quarterly and semi-annually; Affected
Public: Business or other for-profit;
Number of Respondents: 4,526; Total
Annual Responses: 343,976; Total
Annual Hours: 154,610.
3. Type of Information Collection
Request: Extension of a currently
approved collection; Title of
Information Collection: Electronic Data
Interchange (EDI Enrollment Form and
Medicare EDI Registration Form; Form
No.: CMS–10164 (OMB # 0938–983);
Use: Federal law requires that CMS take
precautions to minimize the security
risk to Federal information systems.
Accordingly, CMS is requiring that
trading partners who wish to conduct
the Electronic Data Interchange (EDI)
transactions provide certain assurances
as a condition of receiving access to the
Medicare system for the purpose of
conducting EDI exchanges. Health care
providers, clearinghouses, and health
plans that wish to access the Medicare
system are required to complete this
form. The information will be used to
assure that those entities that access the
Medicare system are aware of applicable
provisions and penalties; Frequency:
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
3051
Recordkeeping and Reporting—Other
(one-time only); Affected Public:
Business or other for-profit, not-forprofit institutions; Number of
Respondents: 240,000; Total Annual
Responses: 240,000; Total Annual
Hours: 80,000.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by March 17, 2009:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number llll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: January 8, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–685 Filed 1–15–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3210–N]
Medicare Program; Meeting of the
Medicare Evidence Development &
Coverage Advisory Committee—March
18, 2009
AGENCY: Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
SUMMARY: This notice announces that a
public meeting of the Medicare
E:\FR\FM\16JAN1.SGM
16JAN1
mstockstill on PROD1PC66 with NOTICES
3052
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
Evidence Development & Coverage
Advisory Committee (MEDCAC)
(‘‘Committee’’) will be held on
Wednesday, March 18, 2009. The
Committee generally provides advice
and recommendations concerning the
adequacy of scientific evidence needed
to determine whether certain medical
items and services can be covered under
the Medicare statute. This meeting will
focus on the use of Bayesian statistics to
interpret evidence in making coverage
decisions. The meeting will introduce
Bayesian concepts, contrast Bayesian
approaches with frequentist approaches,
and provide some examples of using
Bayesian techniques for meta-analyses.
Bayesian analysis is a statistical
technique in which prior evidence is
used to update or to newly infer the
probability that a hypothesis may be
true. This meeting is open to the public
in accordance with the Federal
Advisory Committee Act (5 U.S.C. App.
2, section 10(a)).
DATES: Meeting Date: The public
meeting will be held on Wednesday,
March 18, 2009 from 7:30 a.m. until
4:30 p.m., daylight savings time (d.s.t).
Deadline for Submission of Written
Comments: Written comments must be
received at the address specified in the
ADDRESSES section of this notice by
5 p.m., eastern standard time (e.s.t) on
February 16, 2009. Once submitted, all
comments are final.
Deadline for Speaker Registration and
Presentation Materials: The deadline to
register to be a speaker and to submit
Powerpoint presentation materials and
writings that will be used in support of
an oral presentation, is
5 p.m., e.s.t. on Monday, February 16,
2009. Speakers may register by phone or
via e-mail by contacting the person
listed in the FOR FURTHER INFORMATION
CONTACT section of this notice.
Presentation materials must be received
at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees
Registration: Individuals may register by
phone or via e-mail by contacting the
person listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice by 5 p.m., d.s.t. on Wednesday,
March 11, 2009.
Deadline for Submitting a Request for
Special Accommodations: Persons
attending the meeting who are hearing
or visually impaired, or have a
condition that requires special
assistance or accommodations, are
asked to contact the Executive Secretary
as specified in the FOR FURTHER
INFORMATION CONTACT section of this
notice no later than 5 p.m., d.s.t. Friday,
March 11, 2009.
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
Meeting Location: The
meeting will be held in the main
auditorium of the Centers for Medicare
& Medicaid Services, 7500 Security
Boulevard, Baltimore, MD 21244.
Submission of Presentations and
Comments: Presentation materials and
written comments that will be presented
at the meeting must be submitted via
e-mail to
MedCACpresentations@cms.hhs.gov or
by regular mail to the contact listed in
the FOR FURTHER INFORMATION CONTACT
section of this notice by the date
specified in the DATES section of this
notice.
FOR FURTHER INFORMATION CONTACT:
Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare &
Medicaid Services, Office of Clinical
Standards and Quality, Coverage and
Analysis Group, C1–09–06, 7500
Security Boulevard, Baltimore, MD
21244 or contact Ms. Ellis by phone,
410–786–0309 or via e-mail at
Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
I. Background
MEDCAC, formerly known as the
Medicare Coverage Advisory Committee
(MCAC), provides advice and
recommendations to CMS regarding
clinical issues. (For more information
on MCAC, see the December 14, 1998
Federal Register (63 FR 68780.)) This
notice announces the March 18, 2009,
public meeting of the Committee.
During this meeting, the Committee will
discuss the use of Bayesian statistics to
interpret evidence in making coverage
decisions. The meeting will introduce
Bayesian concepts, contrast Bayesian
approaches with frequentist approaches,
and provide some examples of using
Bayesian techniques for meta-analyses.
Bayesian analysis is a statistical
technique in which prior evidence is
used to update or to newly infer the
probability that a hypothesis may be
true. Background information about this
topic, including panel materials, is
available at https://www.cms.hhs.gov/
coverage. We encourage the
participation of appropriate
organizations with expertise in Bayesian
statistics, meta-analyses, and clinical
trial design and analyses.
II. Meeting Format
This meeting is open to the public.
The Committee will hear oral
presentations from the public for
approximately 45 minutes. The
Committee may limit the number and
duration of oral presentations to the
time available. Your comments should
focus on issues specific to the list of
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
topics that we have proposed to the
Committee. The list of research topics to
be discussed at the meeting will be
available on the following Web site
prior to the meeting: https://
www.cms.hhs.gov/mcd/
index_list.asp?list_type=mcac. We
require that you declare at the meeting
whether you have any financial
involvement with manufacturers (or
their competitors) of any items or
services being discussed.
The Committee will deliberate openly
on the topics under consideration.
Interested persons may observe the
deliberations, but the Committee will
not hear further comments during this
time except at the request of the
chairperson. The Committee will also
allow a 15-minute unscheduled open
public session for any attendee to
address issues specific to the topics
under consideration. At the conclusion
of the day, the members will vote and
the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS’s Coverage and Analysis Group
is coordinating meeting registration.
While there is no registration fee,
individuals must register to attend. You
may register by contacting the person
listed in the FOR FURTHER INFORMATION
CONTACT section of this notice by the
deadline listed in the DATES section of
this notice. Please provide your full
name (as it appears on your state-issued
driver’s license), address, organization,
telephone, fax number(s), and e-mail
address. You will receive a registration
confirmation with instructions for your
arrival at the CMS complex or you will
be notified the seating capacity has been
reached.
IV. Security, Building, and Parking
Guidelines
This meeting will be held in a Federal
government building; therefore, Federal
security measures are applicable. We
recommend that confirmed registrants
arrive reasonably early, but no earlier
than 45 minutes prior to the start of the
meeting, to allow additional time to
clear security. Security measures
include the following:
• Presentation of government-issued
photographic identification to the
Federal Protective Service or Guard
Service personnel.
• Inspection of vehicle’s interior and
exterior (this includes engine and trunk
inspection) at the entrance to the
grounds. Parking permits and
instructions will be issued after the
vehicle inspection.
• Inspection, via metal detector or
other applicable means, of all persons
E:\FR\FM\16JAN1.SGM
16JAN1
Federal Register / Vol. 74, No. 11 / Friday, January 16, 2009 / Notices
entering the building. We note that all
items brought into CMS, whether
personal or for the purpose of
presentation or to support a
presentation, are subject to inspection.
We cannot assume responsibility for
coordinating the receipt, transfer,
transport, storage, set-up, safety, or
timely arrival of any personal
belongings or items used for
presentation or to support a
presentation.
Note: Individuals who are not registered in
advance will not be permitted to enter the
building and will be unable to attend the
meeting. The public may not enter the
building earlier than 45 minutes prior to the
convening of the meeting. All visitors must
be escorted in areas other than the lower and
first floor levels in the Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
Catalog of Federal Domestic Assistance
Program No. 93.773, Medicare—Hospital
Insurance; and Program No. 93.774,
Medicare—Supplementary Medical
Insurance Program.
Dated: January 9, 2009.
Barry M. Straube,
Chief Medical Officer and Director, Office
of Clinical Standards and Quality, Centers
for Medicare & Medicaid Services.
[FR Doc. E9–943 Filed 1–15–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Statement of Mission, Organization,
Functions, and Delegations of
Authority
mstockstill on PROD1PC66 with NOTICES
This notice amends Part K of the
Statement of Mission, Organization,
Functions, and Delegations of Authority
of the Department of Health and Human
Services (HHS), Administration for
Children and Families (ACF), as
follows: Chapter KE, Administration for
Native Americans (ANA), as last
amended in 60 FR 17084–85, 04/04/95.
This notice establishes the Division of
Policy, Planning and Evaluation and
moves the support staff function to the
Office of the Commissioner. The
changes are as follows:
I. Chapter KE. Administration for
Native Americans
A. Delete KE. 00 Mission in its
entirety and replace with the following:
KE. 00 Mission. The mission of the
Administration for Native Americans is
to promote the goal of self-sufficiency
and cultural preservation for Native
Americans by providing social and
VerDate Nov<24>2008
19:02 Jan 15, 2009
Jkt 217001
economic development opportunities
through financial assistance, training,
and technical assistance to eligible
Tribes and Native American
communities, including American
Indians, Alaska Natives, Native
Hawaiians, and other Native Pacific
Islander organizations. ANA provides
funding for community-based projects
that are designed to improve the lives of
Native children and families and reduce
long-term dependency on public
assistance. Competitive funding
authorized under the Native American
Programs Act of 1974, as amended, for
community-based projects is provided
through three competitive discretionary
grant programs to eligible Tribes and
non-profit Native American
organizations: Social and economic
development, language preservation,
and environmental regulatory
enhancement.
B. Delete KE. 10 Organization in its
entirety and replace with the following:
KE.10 Organization. The
Administration for Native Americans is
headed by a Commissioner who is
confirmed by the Senate and reports
directly to the Assistant Secretary for
Children and Families.
The ANA organization includes the:
Office of the Commissioner (KEA); IntraDepartmental Council on Native
American Affairs (KEB); Division of
Program Operations (KEC); Division of
Policy, Planning and Evaluation (KED).
C. Delete KE.20 Functions in its
entirety and replace with the following:
KE. 20 Functions
A. The Office of the Commissioner
provides executive leadership and
management strategies for all
components of ANA. As required by
statute, the Commissioner is Chair of the
Intra-Departmental Council on Native
American Affairs and advises the
Secretary on all matters affecting Native
Americans that involve the Department.
The Commissioner serves as an effective
and visible advocate on behalf of Native
Americans within the Department, and
with other departments and agencies of
the Federal Government regarding all
Federal policies affecting Native
Americans. The Commissioner provides
policy direction and guidance to ACF
Regional Offices with respect to
programs for Urban Indians, offReservation Indians, and other Native
American projects in Hawaii and the
Pacific Islands. The Commissioner
oversees the Native Hawaiian Revolving
Loan Fund administered by the Office of
Hawaiian Affairs. In the absence of the
Commissioner, the Deputy
Commissioner is responsible for all
organizational management.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
3053
The Management Operations Staff
(MOS) is responsible for ANA Budget
and Administrative functions. MOS
coordinates ANA budget activities, the
ANA funding decision memo, data
collection, personnel actions, ANA’s
electronic library, tracking of required
grant reports, and oversees contract
expenditures. The staff members control
the flow of correspondence, including
receipt of and response to Freedom of
Information Act requests.
B. The Commissioner is the Chair of
the Intra-Departmental Council on
Native American Affairs (ICNAA) and
advises the Secretary on Native
American issues. ICNAA staff members
provide support to the Commissioner.
ICNAA develops and promotes HHS
policy to provide greater access and
quality services for American Indians,
Alaska Natives, and Native Americans
(AI/AN/NAs) throughout the
Department and where possible, the
Federal Government; promotes
implementation of HHS policy and
agency plans on consultation with AI/
AN/NAs and Tribal Governments;
identifies and develops legislative,
administrative, and regulatory proposals
that promotes an effective, meaningful
AI/AN/NA policy to improve health and
human services for AI/AN/NAs;
identifies and develops comprehensive
Departmental strategy proposal to
promote self-sufficiency and selfdetermination for all AI/AN/NA people;
and promotes the Tribal/Federal
government-to-government relationship
on a Department-wide basis in
accordance with Presidential Executive
Order.
C. The Division of Program
Operations (DPO) is responsible for the
administration of discretionary grant
programs to eligible Tribes and nonprofit Native American organizations.
The responsibilities include (1) Annual
grant competitions and coordination of
the panel review process, (2)
development of ANA’s Program
Announcements, (3) grant oversight,
and (4) grant close-out procedures. The
DPO also manages and coordinates
activities that support the ACF Native
American Affairs Workgroup.
D. The Division of Policy, Planning
and Evaluation (DPPE) is responsible for
development of organizational policies
and planning; community impact
evaluation; management of quarterly
grantee project assessment; oversight of
training and technical contracts;
coordination of training and technical
assistance activities in Alaska, the
Pacific Basin, and the lower forty-eight
states; development of organizational
and Congressional reports; and
completion of special organizational
E:\FR\FM\16JAN1.SGM
16JAN1
]]>Agencies
[Federal Register Volume 74, Number 11 (Friday, January 16, 2009)]
[Notices]
[Pages 3051-3053]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-943]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3210-N]
Medicare Program; Meeting of the Medicare Evidence Development &
Coverage Advisory Committee--March 18, 2009
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces that a public meeting of the Medicare
[[Page 3052]]
Evidence Development & Coverage Advisory Committee (MEDCAC)
(``Committee'') will be held on Wednesday, March 18, 2009. The
Committee generally provides advice and recommendations concerning the
adequacy of scientific evidence needed to determine whether certain
medical items and services can be covered under the Medicare statute.
This meeting will focus on the use of Bayesian statistics to interpret
evidence in making coverage decisions. The meeting will introduce
Bayesian concepts, contrast Bayesian approaches with frequentist
approaches, and provide some examples of using Bayesian techniques for
meta-analyses. Bayesian analysis is a statistical technique in which
prior evidence is used to update or to newly infer the probability that
a hypothesis may be true. This meeting is open to the public in
accordance with the Federal Advisory Committee Act (5 U.S.C. App. 2,
section 10(a)).
DATES: Meeting Date: The public meeting will be held on Wednesday,
March 18, 2009 from 7:30 a.m. until 4:30 p.m., daylight savings time
(d.s.t).
Deadline for Submission of Written Comments: Written comments must
be received at the address specified in the ADDRESSES section of this
notice by 5 p.m., eastern standard time (e.s.t) on February 16, 2009.
Once submitted, all comments are final.
Deadline for Speaker Registration and Presentation Materials: The
deadline to register to be a speaker and to submit Powerpoint
presentation materials and writings that will be used in support of an
oral presentation, is 5 p.m., e.s.t. on Monday, February 16, 2009.
Speakers may register by phone or via e-mail by contacting the person
listed in the FOR FURTHER INFORMATION CONTACT section of this notice.
Presentation materials must be received at the address specified in the
ADDRESSES section of this notice.
Deadline for All Other Attendees Registration: Individuals may
register by phone or via e-mail by contacting the person listed in the
FOR FURTHER INFORMATION CONTACT section of this notice by 5 p.m.,
d.s.t. on Wednesday, March 11, 2009.
Deadline for Submitting a Request for Special Accommodations:
Persons attending the meeting who are hearing or visually impaired, or
have a condition that requires special assistance or accommodations,
are asked to contact the Executive Secretary as specified in the FOR
FURTHER INFORMATION CONTACT section of this notice no later than 5
p.m., d.s.t. Friday, March 11, 2009.
ADDRESSES: Meeting Location: The meeting will be held in the main
auditorium of the Centers for Medicare & Medicaid Services, 7500
Security Boulevard, Baltimore, MD 21244.
Submission of Presentations and Comments: Presentation materials
and written comments that will be presented at the meeting must be
submitted via e-mail to MedCACpresentations@cms.hhs.gov or by regular
mail to the contact listed in the FOR FURTHER INFORMATION CONTACT
section of this notice by the date specified in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Maria Ellis, Executive Secretary for
MEDCAC, Centers for Medicare & Medicaid Services, Office of Clinical
Standards and Quality, Coverage and Analysis Group, C1-09-06, 7500
Security Boulevard, Baltimore, MD 21244 or contact Ms. Ellis by phone,
410-786-0309 or via e-mail at Maria.Ellis@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
MEDCAC, formerly known as the Medicare Coverage Advisory Committee
(MCAC), provides advice and recommendations to CMS regarding clinical
issues. (For more information on MCAC, see the December 14, 1998
Federal Register (63 FR 68780.)) This notice announces the March 18,
2009, public meeting of the Committee. During this meeting, the
Committee will discuss the use of Bayesian statistics to interpret
evidence in making coverage decisions. The meeting will introduce
Bayesian concepts, contrast Bayesian approaches with frequentist
approaches, and provide some examples of using Bayesian techniques for
meta-analyses. Bayesian analysis is a statistical technique in which
prior evidence is used to update or to newly infer the probability that
a hypothesis may be true. Background information about this topic,
including panel materials, is available at https://www.cms.hhs.gov/coverage. We encourage the participation of appropriate organizations
with expertise in Bayesian statistics, meta-analyses, and clinical
trial design and analyses.
II. Meeting Format
This meeting is open to the public. The Committee will hear oral
presentations from the public for approximately 45 minutes. The
Committee may limit the number and duration of oral presentations to
the time available. Your comments should focus on issues specific to
the list of topics that we have proposed to the Committee. The list of
research topics to be discussed at the meeting will be available on the
following Web site prior to the meeting: https://www.cms.hhs.gov/mcd/index_list.asp?list_type=mcac. We require that you declare at the
meeting whether you have any financial involvement with manufacturers
(or their competitors) of any items or services being discussed.
The Committee will deliberate openly on the topics under
consideration. Interested persons may observe the deliberations, but
the Committee will not hear further comments during this time except at
the request of the chairperson. The Committee will also allow a 15-
minute unscheduled open public session for any attendee to address
issues specific to the topics under consideration. At the conclusion of
the day, the members will vote and the Committee will make its
recommendation(s) to CMS.
III. Registration Instructions
CMS's Coverage and Analysis Group is coordinating meeting
registration. While there is no registration fee, individuals must
register to attend. You may register by contacting the person listed in
the FOR FURTHER INFORMATION CONTACT section of this notice by the
deadline listed in the DATES section of this notice. Please provide
your full name (as it appears on your state-issued driver's license),
address, organization, telephone, fax number(s), and e-mail address.
You will receive a registration confirmation with instructions for your
arrival at the CMS complex or you will be notified the seating capacity
has been reached.
IV. Security, Building, and Parking Guidelines
This meeting will be held in a Federal government building;
therefore, Federal security measures are applicable. We recommend that
confirmed registrants arrive reasonably early, but no earlier than 45
minutes prior to the start of the meeting, to allow additional time to
clear security. Security measures include the following:
Presentation of government-issued photographic
identification to the Federal Protective Service or Guard Service
personnel.
Inspection of vehicle's interior and exterior (this
includes engine and trunk inspection) at the entrance to the grounds.
Parking permits and instructions will be issued after the vehicle
inspection.
Inspection, via metal detector or other applicable means,
of all persons
[[Page 3053]]
entering the building. We note that all items brought into CMS, whether
personal or for the purpose of presentation or to support a
presentation, are subject to inspection. We cannot assume
responsibility for coordinating the receipt, transfer, transport,
storage, set-up, safety, or timely arrival of any personal belongings
or items used for presentation or to support a presentation.
Note: Individuals who are not registered in advance will not be
permitted to enter the building and will be unable to attend the
meeting. The public may not enter the building earlier than 45
minutes prior to the convening of the meeting. All visitors must be
escorted in areas other than the lower and first floor levels in the
Central Building.
Authority: 5 U.S.C. App. 2, section 10(a).
Catalog of Federal Domestic Assistance Program No. 93.773,
Medicare--Hospital Insurance; and Program No. 93.774, Medicare--
Supplementary Medical Insurance Program.
Dated: January 9, 2009.
Barry M. Straube,
Chief Medical Officer and Director, Office of Clinical Standards and
Quality, Centers for Medicare & Medicaid Services.
[FR Doc. E9-943 Filed 1-15-09; 8:45 am]
BILLING CODE 4120-01-P
